<?xml version="1.0"?>

<document>
	<title>Studies on the basic defect in cystic fibrosis: the kinin hypothesis.</title>

	<author>Dann-L-G.</author>
	<author>Blau-K.</author>

	<source>J-Inherited-Metab-Dis. 1978. 1(4). P 179-81.</source>

	<abstract>It is our hypothesis that in cystic fibrosis there is a genetically
   determined specific deficiency in the activity of either the
   glandular kallikrein or in its activating enzyme, and that this
   defect is the primary defect in the disease.  The immediate
   consequence of either of these defects is the absence of kallidin and
   the resulting failure of reabsorption.  The fact that there may be
   mutations affecting distinct enzymes could account for the genetic
   heterogeneity of cystic fibrosis.  A consequence of a defective
   kallikrein system would be accumulation of a precursor related to the
   low molecular weight kininogen and we propose that this compound is
   the ciliary-dyskinesia factor.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: pp</majorsubject>
	<majorsubject>KININS: ph</majorsubject>

	<minorsubject>EXOCRINE-GLANDS: pp</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MODELS-BIOLOGICAL</minorsubject>

	<reference>001   BENKE PJ              IN: MANGOS JA                        157 976</reference>
	<reference>002   CHAN KYH              CLIN CHIM ACTA                  74    71 977</reference>
	<reference>003   DANN LG               LANCET                           2   405 978</reference>
	<reference>004   DIETL T               HOPPE SEYLERS Z PHYSIOL CHEM   359   499 978</reference>
	<reference>005   EMRICH HM             PEDIATR RES                      2   464 968</reference>
	<reference>006   GARRETT JR            ARCH ORAL BIOL                  12  1417 967</reference>
	<reference>007   KAISER D              LANCET                           1  1003 970</reference>
	<reference>008   LOBECK CC             IN: STANBURY JB                     1605 972</reference>
	<reference>009   MCKUSICK VA           MENDELIAN INHERIT IN MAN             468 978</reference>
	<reference>010   MANGOS JA             AM J PHYSIOL                   224  1235 973</reference>
	<reference>011   MANGOS JA             PEDIATR RES                      2   378 968</reference>
	<reference>012   MANGOS JA             IN: MANGOS JA                        311 976</reference>
	<reference>013   MUNGER BL             J BIOPHYS BIOCHEM CYTOL         11   385 961</reference>
	<reference>014   NUSTAD K              GEN PHARMAC                      9     1 978</reference>
	<reference>015   ORSTAVIK TB           ACTA HISTOCHEM                  54   183 975</reference>
	<reference>016   POTTER JL             ANN NY ACAD SCI                106   692 963</reference>
	<reference>017   RAO GJS               PEDIATR RES                      9   739 975</reference>
	<reference>018   SELINGER Z            IN: CARAFOLI E                       139 975</reference>
	<reference>019   SCHRAMM M             J CYCLIC NUCLEOTIDES RES         1   181 975</reference>
	<reference>020   SUTCLIFFE CH          PROC R SOC MED                  61   297 968</reference>
	<reference>021   ULLRICH KJ            IN: THORN NA                         423 974</reference>
	<reference>022   WEBSTER ME            BIOCHEM PHARMACOL               12   511 963</reference>


</document>
